794 related articles for article (PubMed ID: 32251636)
1. Inhibition of the NLRP3 inflammasome reduces brain edema and regulates the distribution of aquaporin-4 after cerebral ischaemia-reperfusion.
Wang H; Chen H; Jin J; Liu Q; Zhong D; Li G
Life Sci; 2020 Jun; 251():117638. PubMed ID: 32251636
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice.
Wang H; Zhong D; Chen H; Jin J; Liu Q; Li G
Life Sci; 2019 Jun; 227():101-113. PubMed ID: 31002919
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the NLRP3-inflammasome as a potential approach for neuroprotection after stroke.
Ismael S; Zhao L; Nasoohi S; Ishrat T
Sci Rep; 2018 Apr; 8(1):5971. PubMed ID: 29654318
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent dual effect of NLRP3 inflammasome in brain ischaemia.
Palomino-Antolin A; Narros-Fernández P; Farré-Alins V; Sevilla-Montero J; Decouty-Pérez C; Lopez-Rodriguez AB; Fernández N; Monge L; Casas AI; Calzada MJ; Egea J
Br J Pharmacol; 2022 Apr; 179(7):1395-1410. PubMed ID: 34773639
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice.
Hong P; Li FX; Gu RN; Fang YY; Lai LY; Wang YW; Tao T; Xu SY; You ZJ; Zhang HF
Neural Plast; 2018; 2018():9163521. PubMed ID: 29853850
[TBL] [Abstract][Full Text] [Related]
6. Aloe-emodin alleviates cerebral ischemia-reperfusion injury by regulating microglial polarization and pyroptosis through inhibition of NLRP3 inflammasome activation.
Li X; Yao M; Li L; Ma H; Sun Y; Lu X; Jing W; Nie S
Phytomedicine; 2024 Jul; 129():155578. PubMed ID: 38621328
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 inflammasome inhibition with MCC950 improves diabetes-mediated cognitive impairment and vasoneuronal remodeling after ischemia.
Ward R; Li W; Abdul Y; Jackson L; Dong G; Jamil S; Filosa J; Fagan SC; Ergul A
Pharmacol Res; 2019 Apr; 142():237-250. PubMed ID: 30818045
[TBL] [Abstract][Full Text] [Related]
8. NLPR3 inflammasome inhibition alleviates hypoxic endothelial cell death in vitro and protects blood-brain barrier integrity in murine stroke.
Bellut M; Papp L; Bieber M; Kraft P; Stoll G; Schuhmann MK
Cell Death Dis; 2021 Dec; 13(1):20. PubMed ID: 34930895
[TBL] [Abstract][Full Text] [Related]
9. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
[TBL] [Abstract][Full Text] [Related]
10. Effects of NLRP3 inflammasome blockade on postresuscitation cerebral function in a rat model of cardiopulmonary resuscitation.
Zheng G; Xu J; He F; Hu J; Ge W; Ji X; Wang C; Bradley JL; Peberdy MA; Ornato JP; Toldo S; Wang T; Tang W
Biomed Pharmacother; 2021 Nov; 143():112093. PubMed ID: 34474352
[TBL] [Abstract][Full Text] [Related]
11. MCC950 attenuated early brain injury by suppressing NLRP3 inflammasome after experimental SAH in rats.
Luo Y; Lu J; Ruan W; Guo X; Chen S
Brain Res Bull; 2019 Mar; 146():320-326. PubMed ID: 30716395
[TBL] [Abstract][Full Text] [Related]
12. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats.
Zhao J; Guo X; Wang B; Yang Z; Huang T; Guo D; Zhang M; Song J
Neurochem Res; 2020 Sep; 45(9):2020-2031. PubMed ID: 32474832
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 inflammasome inhibitor MCC950 reduces cerebral ischemia/reperfusion induced neuronal ferroptosis.
Wu X; Wang B; Zhou Y; Yang Z; Jiang L; Kou Z; Li J; Ma X; Song J
Neurosci Lett; 2023 Jan; 795():137032. PubMed ID: 36581063
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression.
Wang S; Yao Q; Wan Y; Wang J; Huang C; Li D; Yang B
Int J Neurosci; 2020 Mar; 130(3):301-308. PubMed ID: 31607194
[No Abstract] [Full Text] [Related]
15. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation.
Jiang M; Li R; Lyu J; Li X; Wang W; Wang Z; Sheng H; Zhang W; Karhausen J; Yang W
J Neuroinflammation; 2020 Aug; 17(1):256. PubMed ID: 32867797
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1β and islet cellular death.
Matsuoka T; Yoshimatsu G; Sakata N; Kawakami R; Tanaka T; Yamada T; Yoshida Y; Hasegawa S; Kodama S
Sci Rep; 2020 Oct; 10(1):17920. PubMed ID: 33087823
[TBL] [Abstract][Full Text] [Related]
18. The NLRP3 inflammasome drives inflammation in ischemia/reperfusion injury after transient middle cerebral artery occlusion in mice.
Franke M; Bieber M; Kraft P; Weber ANR; Stoll G; Schuhmann MK
Brain Behav Immun; 2021 Feb; 92():223-233. PubMed ID: 33307174
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of Vinpocetine Against Ischemia-Reperfusion Injury Via Inhibiting NLRP3 Inflammasome Signaling Pathway.
Hou B; Li D; Wang D; Jiang C; Wang G; Wang D; Yan G; Guo X; Zhao L; Wan Z; Fan C; Cao W; Ren H
Neuroscience; 2023 Aug; 526():74-84. PubMed ID: 37290685
[TBL] [Abstract][Full Text] [Related]
20. MCC950, the Selective Inhibitor of Nucleotide Oligomerization Domain-Like Receptor Protein-3 Inflammasome, Protects Mice against Traumatic Brain Injury.
Ismael S; Nasoohi S; Ishrat T
J Neurotrauma; 2018 Jun; 35(11):1294-1303. PubMed ID: 29295651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
